{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:53:14Z","timestamp":1791640394954,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,10]]},"DOI":"10.7759\/cureus.117729","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:21:09Z","timestamp":1791638469000},"source":"Crossref","is-referenced-by-count":0,"title":["Selective Serotonin Reuptake Inhibitor-Associated Bruxism: Neuropharmacologic Mechanisms and Clinical Implications"],"prefix":"10.7759","author":[{"given":"Binh","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/joor.13985","article-title":"Updating the bruxism definitions: report of an international consensus meeting","volume":"52","author":"Verhoeff MC","year":"2025","unstructured":"Verhoeff MC, Lobbezoo F, Ahlberg J, et al.. Updating the bruxism definitions: report of an international consensus meeting. J Oral Rehabil. 2025, 52:1335-42. 10.1111\/joor.13985","journal-title":"J Oral Rehabil"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/joor.12663","article-title":"International consensus on the assessment of bruxism: report of a work in progress","volume":"45","author":"Lobbezoo F","year":"2018","unstructured":"Lobbezoo F, Ahlberg J, Raphael KG, et al.. International consensus on the assessment of bruxism: report of a work in progress. J Oral Rehabil. 2018, 45:837-44. 10.1111\/joor.12663","journal-title":"J Oral Rehabil"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2842.2001.00839.x","article-title":"Bruxism is mainly regulated centrally, not peripherally","volume":"28","author":"Lobbezoo F","year":"2001","unstructured":"Lobbezoo F, Naeije M. Bruxism is mainly regulated centrally, not peripherally. J Oral Rehabil. 2001, 28:1085-91. 10.1046\/j.1365-2842.2001.00839.x","journal-title":"J Oral Rehabil"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/154411130301400104","article-title":"Neurobiological mechanisms involved in sleep bruxism","volume":"14","author":"Lavigne GJ","year":"2003","unstructured":"Lavigne GJ, Kato T, Kolta A, Sessle BJ. Neurobiological mechanisms involved in sleep bruxism. Crit Rev Oral Biol Med. 2003, 14:30-46. 10.1177\/154411130301400104","journal-title":"Crit Rev Oral Biol Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/00220345010800101501","article-title":"Sleep bruxism: an oromotor activity secondary to micro-arousal","volume":"80","author":"Kato T","year":"2001","unstructured":"Kato T, Rompr\u00e9 P, Montplaisir JY, Sessle BJ, Lavigne GJ. Sleep bruxism: an oromotor activity secondary to micro-arousal. J Dent Res. 2001, 80:1940-4. 10.1177\/00220345010800101501","journal-title":"J Dent Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.job.2023.04.005","article-title":"Understanding the pathophysiology of sleep bruxism based on human and animal studies: a narrative review","volume":"65","author":"Kato T","year":"2023","unstructured":"Kato T, Higashiyama M, Katagiri A, et al.. Understanding the pathophysiology of sleep bruxism based on human and animal studies: a narrative review. J Oral Biosci. 2023, 65:156-62. 10.1016\/j.job.2023.04.005","journal-title":"J Oral Biosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cden.2012.01.003","article-title":"Sleep bruxism: a comprehensive overview for the dental clinician interested in sleep medicine","volume":"56","author":"Carra MC","year":"2012","unstructured":"Carra MC, Huynh N, Lavigne G. Sleep bruxism: a comprehensive overview for the dental clinician interested in sleep medicine. Dent Clin North Am. 2012, 56:387-413. 10.1016\/j.cden.2012.01.003","journal-title":"Dent Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000433","article-title":"SSRI-associated bruxism: a systematic review of published case reports","volume":"8","author":"Garrett AR","year":"2018","unstructured":"Garrett AR, Hawley JS. SSRI-associated bruxism: a systematic review of published case reports. Neurol Clin Pract. 2018, 8:135-41. 10.1212\/CPJ.0000000000000433","journal-title":"Neurol Clin Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000108","article-title":"Antidepressant-induced sleep bruxism: prevalence, incidence, and related factors","volume":"38","author":"Uca AU","year":"2015","unstructured":"Uca AU, U\u011fuz F, Kozak HH, G\u00fcm\u00fc\u015f H, Aksoy F, Seyithano\u011flu A, Kurt HG. Antidepressant-induced sleep bruxism: prevalence, incidence, and related factors. Clin Neuropharmacol. 2015, 38:227-30. 10.1097\/WNF.0000000000000108","journal-title":"Clin Neuropharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v60n1209","article-title":"Buspirone as an antidote to SSRI-induced bruxism in 4 cases","volume":"60","author":"Bostwick JM","year":"1999","unstructured":"Bostwick JM, Jaffee MS. Buspirone as an antidote to SSRI-induced bruxism in 4 cases. J Clin Psychiatry. 1999, 60:857-60. 10.4088\/jcp.v60n1209","journal-title":"J Clin Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-4505.2009.00091.x","article-title":"Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report","volume":"29","author":"Sabuncuoglu O","year":"2009","unstructured":"Sabuncuoglu O, Ekinci O, Berkem M. Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report. Spec Care Dentist. 2009, 29:215-7. 10.1111\/j.1754-4505.2009.00091.x","journal-title":"Spec Care Dentist"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15884","article-title":"Drugs and bruxism: a study in the World Health Organization's pharmacovigilance database","volume":"89","author":"Montastruc JL","year":"2023","unstructured":"Montastruc JL. Drugs and bruxism: a study in the World Health Organization's pharmacovigilance database. Br J Clin Pharmacol. 2023, 89:3765-8. 10.1111\/bcp.15884","journal-title":"Br J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02711-z","article-title":"Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database","volume":"20","author":"Revet A","year":"2020","unstructured":"Revet A, Montastruc F, Roussin A, Raynaud JP, Lapeyre-Mestre M, Nguyen TT. Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database. BMC Psychiatry. 2020, 20:308. 10.1186\/s12888-020-02711-z","journal-title":"BMC Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1726-1","article-title":"Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex","volume":"173","author":"Liu YP","year":"2004","unstructured":"Liu YP, Wilkinson LS, Robbins TW. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex. Psychopharmacology (Berl). 2004, 173:175-85. 10.1007\/s00213-003-1726-1","journal-title":"Psychopharmacology (Berl)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex KD","year":"2007","unstructured":"Alex KD, Pehek EA. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther. 2007, 113:296-320. 10.1016\/j.pharmthera.2006.08.004","journal-title":"Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(02)17","article-title":"Paroxetine-induced severe sleep bruxism successfully treated with buspirone","volume":"67","author":"Milanlioglu A","year":"2012","unstructured":"Milanlioglu A. Paroxetine-induced severe sleep bruxism successfully treated with buspirone. Clinics (Sao Paulo). 2012, 67:191-2. 10.6061\/clinics\/2012(02)17","journal-title":"Clinics (Sao Paulo)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181c0e942","article-title":"Bruxism associated with serotonin reuptake inhibitors: two cases","volume":"29","author":"Ak M","year":"2009","unstructured":"Ak M, Gulsun M, Uzun O, Gumus HO. Bruxism associated with serotonin reuptake inhibitors: two cases. J Clin Psychopharmacol. 2009, 29:620-2. 10.1097\/JCP.0b013e3181c0e942","journal-title":"J Clin Psychopharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-026-05834-1","article-title":"Sertraline-induced bruxism: a case report and review of the literature","volume":"20","author":"Kohat K","year":"2026","unstructured":"Kohat K, Chenchula S. Sertraline-induced bruxism: a case report and review of the literature. J Med Case Rep. 2026, 20:137. 10.1186\/s13256-026-05834-1","journal-title":"J Med Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2016.12.013","article-title":"BiteStrip analysis of the effect of fluoxetine and paroxetine on sleep bruxism","volume":"80","author":"Isa Kara M","year":"2017","unstructured":"Isa Kara M, Erta\u015f ET, Ozen E, At\u0131c\u0131 M, Aksoy S, Erdogan MS, Kelebek S. BiteStrip analysis of the effect of fluoxetine and paroxetine on sleep bruxism. Arch Oral Biol. 2017, 80:69-74. 10.1016\/j.archoralbio.2016.12.013","journal-title":"Arch Oral Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jormas.2026.102710","article-title":"Prevalence of bruxism in users of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors: a retrospective cross-sectional study","volume":"127","author":"Santos IM","year":"2026","unstructured":"Santos IM, Machado EV, de Oliveira DW, Flecha OD, Leonan-Silva B. Prevalence of bruxism in users of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors: a retrospective cross-sectional study. J Stomatol Oral Maxillofac Surg. 2026, 127:102710. 10.1016\/j.jormas.2026.102710","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.adaj.2026.04.016","article-title":"Assessment of self-reported and clinically reported bruxism in studies on selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors use: a critical appraisal aligned with the Standardized Tool for the Assessment of Bruxism principles","author":"Leonan-Silva B","year":"2026","unstructured":"Leonan-Silva B, Manfredini D, Machado EV, da Silva Filho VF, Rodarte L, Flecha OD, Saracutu OI. Assessment of self-reported and clinically reported bruxism in studies on selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors use: a critical appraisal aligned with the Standardized Tool for the Assessment of Bruxism principles. J Am Dent Assoc. 2026, 10.1016\/j.adaj.2026.04.016","journal-title":"J Am Dent Assoc"},{"key":"ref22","article-title":"SSRI-associated nocturnal bruxism in four patients","volume":"54","author":"Ellison JM","year":"1993","unstructured":"Ellison JM, Stanziani P. SSRI-associated nocturnal bruxism in four patients. J Clin Psychiatry. 1993, 54:432-4.","journal-title":"J Clin Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.700714","article-title":"Oromandibular dystonia: a clinical examination of 2,020 cases","volume":"12","author":"Scorr LM","year":"2021","unstructured":"Scorr LM, Factor SA, Parra SP, et al.. Oromandibular dystonia: a clinical examination of 2,020 cases. Front Neurol. 2021, 12:700714. 10.3389\/fneur.2021.700714","journal-title":"Front Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2903","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants","volume":"114","author":"Bousman CA","year":"2023","unstructured":"Bousman CA, Stevenson JM, Ramsey LB, et al.. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther. 2023, 114:51-68. 10.1002\/cpt.2903","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/526091-selective-serotonin-reuptake-inhibitor-associated-bruxism-neuropharmacologic-mechanisms-and-clinical-implications","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:21:10Z","timestamp":1791638470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/526091-selective-serotonin-reuptake-inhibitor-associated-bruxism-neuropharmacologic-mechanisms-and-clinical-implications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.117729","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,10]]}}}